BBVA USA Bancshares Inc. Has $851,000 Holdings in Itron, Inc. (NASDAQ:ITRI)

BBVA USA Bancshares Inc. lifted its stake in Itron, Inc. (NASDAQ:ITRI) by 19.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 11,509 shares of the scientific and technical instruments company’s stock after buying an additional 1,895 shares during the period. BBVA USA Bancshares Inc.’s holdings in Itron were worth $851,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. BlackRock Inc. raised its holdings in shares of Itron by 1.2% in the 2nd quarter. BlackRock Inc. now owns 4,987,689 shares of the scientific and technical instruments company’s stock worth $312,079,000 after buying an additional 60,154 shares in the last quarter. Bogle Investment Management L P DE acquired a new position in shares of Itron in the 2nd quarter worth approximately $587,000. Louisiana State Employees Retirement System raised its holdings in shares of Itron by 4.0% in the 3rd quarter. Louisiana State Employees Retirement System now owns 13,000 shares of the scientific and technical instruments company’s stock worth $961,000 after buying an additional 500 shares in the last quarter. First Trust Advisors LP raised its holdings in shares of Itron by 11.9% in the 3rd quarter. First Trust Advisors LP now owns 468,374 shares of the scientific and technical instruments company’s stock worth $34,641,000 after buying an additional 49,746 shares in the last quarter. Finally, Alps Advisors Inc. raised its holdings in shares of Itron by 97.3% in the 2nd quarter. Alps Advisors Inc. now owns 54,645 shares of the scientific and technical instruments company’s stock worth $3,419,000 after buying an additional 26,944 shares in the last quarter. 94.22% of the stock is owned by institutional investors and hedge funds.

In other Itron news, CEO Philip Mezey sold 31,420 shares of Itron stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $72.81, for a total value of $2,287,690.20. Following the sale, the chief executive officer now owns 91,206 shares of the company’s stock, valued at approximately $6,640,708.86. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Thomas S. Glanville sold 1,000 shares of Itron stock in a transaction dated Friday, October 11th. The shares were sold at an average price of $75.10, for a total value of $75,100.00. Following the completion of the sale, the director now directly owns 11,056 shares in the company, valued at approximately $830,305.60. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 74,667 shares of company stock worth $5,385,885. Corporate insiders own 2.35% of the company’s stock.

A number of equities research analysts recently weighed in on ITRI shares. TheStreet raised Itron from a “c+” rating to a “b-” rating in a report on Friday, August 16th. Stephens set a $83.00 price target on Itron and gave the company a “hold” rating in a report on Friday, October 18th. Argus raised Itron from a “hold” rating to a “buy” rating in a report on Friday, August 16th. Credit Suisse Group cut Itron to an “outperform” rating in a report on Tuesday, August 20th. Finally, Raymond James raised their price target on Itron from $75.00 to $82.00 and gave the company an “outperform” rating in a report on Tuesday, October 1st. Two research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. Itron has an average rating of “Buy” and an average price target of $77.18.

Shares of ITRI opened at $76.16 on Friday. Itron, Inc. has a 52 week low of $44.35 and a 52 week high of $81.29. The company has a debt-to-equity ratio of 1.31, a quick ratio of 1.07 and a current ratio of 1.41. The firm has a market capitalization of $3.10 billion, a price-to-earnings ratio of 28.74, a PEG ratio of 1.01 and a beta of 1.09. The business’s fifty day moving average price is $75.74 and its two-hundred day moving average price is $66.20.

Itron (NASDAQ:ITRI) last posted its quarterly earnings results on Monday, November 4th. The scientific and technical instruments company reported $1.04 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.66 by $0.38. Itron had a return on equity of 18.69% and a net margin of 2.37%. The business had revenue of $624.47 million for the quarter, compared to analyst estimates of $622.63 million. During the same period last year, the company earned $1.13 EPS. The firm’s revenue was up 4.8% on a year-over-year basis. As a group, research analysts forecast that Itron, Inc. will post 3.09 EPS for the current year.

Itron Company Profile

Itron, Inc, a technology and service company, provides end-to-end solutions that measures, manages, and analyzes energy and water use worldwide. The company operates through three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing.

Further Reading: What is Put Option Volume?

Want to see what other hedge funds are holding ITRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Itron, Inc. (NASDAQ:ITRI).

Institutional Ownership by Quarter for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.